Optimizing Evidence-based HIV Prevention Targeting People Who Inject Drugs on PrEP | MicrobiomeTrials← Back to trialsNCT05669534
Optimizing Evidence-based HIV Prevention Targeting People Who Inject Drugs on PrEP
RecruitingPHASE4INTERVENTIONAL
Trial Details
Start: 2023-03-01Est. Completion: 2027-01
Enrollment target: 256 participants Locations- APT Foundation, New Haven, Connecticut, United States
Other microbiome trials you might be interested in
HIV Infections
This study compares the efficacy, safety and tolerability of CAB ULA and RPV ULA administered with CAB long acting (LA) …
Multiple LocationsEst. completion Sep 4, 2029
Sexually Transmitted Diseases
The aim of this first time in human proof of concept (FTiH-PoC) study was to evaluate safety and reactogenicity, to demo…
Washington D.C., United StatesCompleted May 22, 2025
Recruiting
Risky Sexual BehaviorEmotion RegulationAdolescent Behavior
Using the efficacious iTRAC intervention to enhance emotion regulation competencies as a foundation, this study will cre…
Golden, United StatesEst. completion Aug 8, 2026